Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation

Heart Rhythm

Volumn 6, Issue 11, 2009, Pages 1565-1571

  Aggarwal, Atul ^a   Wang, Yongfei ^b   Rumsfeld, John S ^c   Curtis, Jeptha P ^b   Heidenreich, Paul A ^d  

^a Comprehensive Cardiovascular Medical Group ^*  (United States)

^b YALE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Defibrillator; Dialysis; Renal failure

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ARTERIOVENOUS FISTULA; ARTICLE; CARDIAC PERFORATION; COMORBIDITY; CONTROLLED STUDY; CORONARY VENOUS DISSECTION; DEFIBRILLATOR; DISEASE REGISTRY; EMBOLISM; FEMALE; HEART ARREST; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERFORATION; PERIPHERAL NERVE INJURY; PHLEBITIS; PNEUMOTHORAX; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS INFECTION; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; VALVULAR HEART DISEASE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 70350505796     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.08.006     Document Type: Article

References (20)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 52 (2005) 225-237
3. Moss A.J., Zareba W., Hall W.J., et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
4. Buxton A.E., Lee K.L., DiCarlo L., et al., Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945 29
5. Goldenberg I., and Moss A.J. Implantable device therapy. Prog Cardiovasc Dis 50 (2008) 449-474
6. Hreybe H., Razak E., and Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 30 (2007) 1091-1095
7. Herzog C.A., Mangrum J.M., and Passman R. Sudden cardiac death and dialysis patients. Semin Dial 21 (2008) 300-307
8. Robin J., Weinberg K., Tiongson J., et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 3 (2006) 1196-1201
9. Zoccali C., Mallamaci F., and Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15 Suppl 1 (2004) S77-S80
10. Wase A., Basit A., Nazir R., et al. Impact of chronic kidney disease among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 11 (2004) 199-204
11. Hreybe H., Ezzeddine R., Bedi M., et al. Renal insufficiency predicts time to first appropriate defibrillator shock. Am Heart J 151 (2006) 852-856
12. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 5 (2008) 1359-1363
13. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). In: Woosley R.L., and Singh S.N. (Eds). Arrhythmia Treatment and Therapy: Evaluation of Clinical Trial Evidence (2000), Marcel Dekker, New York 323-327
14. Moss A.J., Daubert J.P., Hall W.J., et al. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): design and clinical protocol. Ann Noninvasive Electrocardiol 4 (1999) 83-91
15. Ranchord A.M., Harding S.A., and Pidgeon G. Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients. Intern Med J 38 (2008) 361-364
16. Desai A. Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation 118 (2008) 1609-1611
17. Berger A.K., Duval S., and Krumholz H.M. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42 (2003) 201-208
18. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137 (2002) 563-570
19. Pyun P.H., Lehrich R.W., Smith S.R., et al. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2 (2007) 491-500
20. Dasgupta A., Montalvo J., Medendorp S., et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 49 (2007) 656-663